| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer
1 company
Van Houte Hans is a Chief Financial Officer at Nurix Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 8 sells.
Estimated insider holdings value: $1.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 2, 2022 | NRIX Nurix Therapeutics, Inc. | Chief Financial Officer | Sale+OE | 697 | $11.75 | $8,189.75 | -24.2% | +28.8% | -21.4% | |
| Feb 24, 2021 | NRIX Nurix Therapeutics, Inc. | Chief Financial Officer | Sale+OE | 35,419 | $39.90 | $1,413,218.10 | -100% | - | - | |
| Feb 22, 2021 | NRIX Nurix Therapeutics, Inc. | Chief Financial Officer | Sale+OE | 5,330 | $39.93 | $212,839.16 | -100% | - | - | |
| Feb 18, 2021 | NRIX Nurix Therapeutics, Inc. | Chief Financial Officer | Sale+OE | 13,583 | $35.46 | $481,621.05 | -42.1% | - | - |